ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 678994 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 678994; 2) Community: the network communities that were significantly associated with the response to NSC 678994; 3) Molecule: the relationships between components within communities and NSC 678994; 4) MDR: the compounds that were significantly associated with the NSC 678994.

NSC Compound Enrichment Correlation
NSC 744020 methyl 1-(4-[(11aR)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxybutyl)-2-(1-methyl-1H-3-indolyl)-1H-benzo[d]imidazole-6-carboxylate 0.0163859626459253 0.21979883
NSC 79304 Null 0.0163859626459253 0.3759296
NSC 109084 Null 0.0163859626459254 0.34574714
NSC 117281 ANTINEOPLASTIC-117281 0.0163859626459254 0.20910926
NSC 12161 Adenosine, 1,2-dihydro-2-oxo- (9CI) 0.0163859626459254 0.11053463
NSC 143095 Pyrazofurin 0.0163859626459254 0.21851216
NSC 2805 2,2',5,5'-Tetrahydroxy-4,4'-dimethylbiphenyl 0.0163859626459254 0.45022005
NSC 294846 Cinnoline, 4-nitro-, 1-oxide 0.0163859626459254 0.28478797
NSC 605440 Isothiazolo[2,3-a]azepine, 5,7-bis(trifluoromethyl)- 2,3-dihydro-, 1,1-dioxide 0.0163859626459254 0.62432713
NSC 623639 Cyclopentane-1,3-dimethanamine, N,N,N,N',N',N'-hexamethyl-2-oxo-, iodide 0.0163859626459254 0.65471914
Total:136  Current:63    [First] [Prev] [Next] [Last]